确定G蛋白子单元α i3作为LUAD的一个有前途的瘤点
Gaomeng Luo1, Wenxuan Hu1, Jian Yang1
1Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China; Institute of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
向G蛋白α-i3 (Gαi3) 抑制肺腺癌 (LUAD) 的生长. Gαi3的过度表达驱动了LUAD细胞的增殖和迁移,而其沉默则促进了细胞亡,并减少了瘤的生体内生长.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 肺腺癌 (LUAD) 细胞生长需要确定新的治疗点.
- G-蛋白α-i3 (Gαi3) 在LUAD上调并与患者生存率较差有关.
研究的目的:
- 研究Gαi3在LUAD进展中的作用,并评估其作为治疗点的潜力.
主要方法:
- 对LUAD组织的生物信息分析.
- 使用shRNA和CRISPR/Cas9.9进行Gαi3表达的基因操纵.
- 对细胞增殖,迁移,亡和线粒体膜潜力的测试.
- 西方涂抹和基因组丰富分析,以探索信号通路.
- 在体内异种移植模型.
主要成果:
- 过度表达Gαi3与LUAD患者的生存率差相关.
- 沉默或淘汰Gαi3抑制LUAD细胞的增殖,迁移,并诱导细胞亡.
- Gαi3通过PI3K/Akt/mTOR通路调节LUAD细胞功能.
- 在体内,通过AAV-shRNA降低Gαi3的调节抑制了异种植的瘤生长.
结论:
- Gαi3是LUAD进展的关键驱动因素.
- 向Gαi3代表了肺腺癌的一个有前途的治疗策略.
更多相关视频
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
相关概念视频
Activation and Inactivation of G Proteins
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Targeted Cancer Therapies
There are several types of targeted therapies against...
lncRNA - Long Non-coding RNAs
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
IP3/DAG Signaling Pathway
